RadioMedix Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $40M

  • Investors
  • 4

RadioMedix General Information

Description

Operator of a biotechnology firm intended to focus on targeted radio-pharmaceuticals for the diagnosis, monitoring, and therapy of cancer. The company offers drug candidate selection, optimization of drug formulation, evaluation of in vitro and in vivo studies in relevant disease models, and a multitude of pre-clinical services, enabling medical scientists to have on-site and on-demand access to radio-chemistry technologies.

Contact Information

Website
www.radiomedix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9701 Richmond Avenue
  • Suite 222
  • Houston, TX 77042
  • United States
+1 (713)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 9701 Richmond Avenue
  • Suite 222
  • Houston, TX 77042
  • United States
+1 (713)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RadioMedix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A) 07-Oct-2022 $40M Completed Clinical Trials - General
8. Grant 18-Nov-2021 Completed Clinical Trials - General
7. Later Stage VC 18-Nov-2021 Cancelled Clinical Trials - General
6. Grant 07-Sep-2021 Completed Clinical Trials - General
5. Grant 01-Jan-2018 Completed Clinical Trials - General
4. Grant 01-Jan-2016 Completed Clinical Trials - General
3. Grant 01-Jan-2014 Completed Clinical Trials - General
2. Later Stage VC 06-Mar-2012 $1.4M $1.4M Completed Clinical Trials - General
1. Grant 10-Feb-2011 $2.8M Completed Clinical Trials - General
To view RadioMedix’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

RadioMedix Patents

  • 49

    Total Documents Applications and Grants

  • Total Patents Families

  • 16

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

RadioMedix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024432652-A1 Automated method and device for production of lead 212 for use in targeted alpha-particle therapy Pending 30-Mar-2023
EP-4688227-A2 Automated method and device for production of lead 212 for use in targeted alpha-particle therapy Pending 30-Mar-2023
US-20240327948-A1 Automated method and device for production of lead 212 for use in targeted alpha-particle therapy Pending 30-Mar-2023
US-20250367574-A1 Automated method and device for production of lead 212 for use in targeted alpha-particle therapy Pending 30-Mar-2023
WO-2025188324-A2 Automated method and device for production of lead 212 for use in targeted alpha-particle therapy Inactive 30-Mar-2023 B01D15/1871
To view RadioMedix’s complete patent history, request access »

RadioMedix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RadioMedix Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Portland Investment Counsel Asset Manager Minority
National Cancer Institute Government
National Institutes of Health Government
Texas Emerging Technology Fund Venture Capital Minority
To view RadioMedix’s complete investors history, request access »

Ready to get started?

Request a free trial

RadioMedix FAQs

  • When was RadioMedix founded?

    RadioMedix was founded in 2006.

  • Where is RadioMedix headquartered?

    RadioMedix is headquartered in Houston, TX.

  • What is the size of RadioMedix?

    RadioMedix has 44 total employees.

  • What industry is RadioMedix in?

    RadioMedix’s primary industry is Drug Discovery.

  • Is RadioMedix a private or public company?

    RadioMedix is a Private company.

  • What is RadioMedix’s current revenue?

    The current revenue for RadioMedix is .

  • How much funding has RadioMedix raised over time?

    RadioMedix has raised $41.4M.

  • Who are RadioMedix’s investors?

    Portland Investment Counsel, National Cancer Institute, National Institutes of Health, and Texas Emerging Technology Fund have invested in RadioMedix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process